The Federal SBIR/STTR programs award over $2.6 billion in high risk R&D funding annually to qualified small businesses. The process is complex with a steep learning curve, but the impact of receiving $millions in non-dilutive funding is worth the effort. This two-hr. session, conducted by nationally recognized SBIR/STTR expert, Lisa Kurek, will provide an overview of SBIR/STTR funding, discuss eligibility requirements, and help participants determine whether or not they should take the next steps in pursuing this compelling source of funding.
The session is provided by SBIR Impact NYC, an initiative of NYCEDC designed to enhance the competitiveness of SBIR/STTR proposals among NYC-based life sciences and healthcare technology companies.
With thanks to our sponsors and hosts: